High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$5.2M
$5,203,232
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2026-03-11
$102,300
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2026-03-11 | $102,300 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 SellΔOwn -40.0%
2026-02-04
$580,197x2
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 SellΔOwn -40.0%
|
2026-02-04 | $580,197x2 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2026-01-07
$220,289
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2026-01-07 | $220,289 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2025-12-11
$107,900
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2025-12-11 | $107,900 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2025-12-10
$105,669
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2025-12-10 | $105,669 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 SellΔOwn -66.7%
2025-11-12
$347,770x2
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 SellΔOwn -66.7%
|
2025-11-12 | $347,770x2 | S | Form 4 |
|
ONC
S
BeOne Medicines Ltd.
Lee Chan Henry
• Officer • SVP, General Counsel
10b5-1 Sell
2025-10-08
$3,739,108Largex4
|
||||||
| ONC |
BeOne Medicines Ltd.
|
Officer • SVP, General Counsel
10b5-1 Sell
|
2025-10-08 | $3,739,108Largex4 | S | Form 4 |